PureTech Health (PRTC) Invested Capital (2019 - 2025)

PureTech Health (PRTC) has 6 years of Invested Capital data on file, last reported at $312.1 million in Q4 2025.

• Quarterly Invested Capital changed N/A year-over-year to $312.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $312.1 million (changed N/A YoY) and the FY2025 annual result came in at $312.1 million, changed N/A from the prior year.
• Invested Capital fell to $312.1 million in Q4 2025 per PRTC's latest filing, from $464.1 million in the prior quarter.
• Across five years, Invested Capital topped out at $645.3 million in Q4 2022 and bottomed at $312.1 million in Q4 2025.
• The 4-year median for Invested Capital is $536.3 million (2021), against an average of $507.5 million.
• The widest annual swing landed in 2022, when Invested Capital advanced 6.03%; it then slipped 28.09% in 2023.
• Tracing PRTC's Invested Capital over 4 years: stood at $608.6 million in 2021, then rose by 6.03% to $645.3 million in 2022, then retreated by 28.09% to $464.1 million in 2023, then slumped by 32.75% to $312.1 million in 2025.
• Per Business Quant, the three latest PRTC Invested Capital figures stand at $312.1 million (Q4 2025), $464.1 million (Q4 2023), and $645.3 million (Q4 2022).

Peer Comparison